• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定通过湿磨介质技术制备的纳米混悬剂制剂的药物/稳定剂性质与关键质量属性(CQAs)之间的相关性。

Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.

机构信息

College of Pharmacy, University of Iowa, 115 S. Grand Avenue, Iowa City, IA 52242, USA.

出版信息

Eur J Pharm Sci. 2013 Jan 23;48(1-2):142-52. doi: 10.1016/j.ejps.2012.10.004. Epub 2012 Oct 22.

DOI:10.1016/j.ejps.2012.10.004
PMID:23085547
Abstract

Wet media milling by top down method has proved to be an effective method to prepare nanosuspension of poorly soluble drugs/APIs. Few or no attempts have been made so far to understand the feasibility of nanosuspension formulation in terms of the mechanism of stabilization as a function of drug properties. The objective of this study was to understand the effect of drug substance and stabilizer properties to form a successful nanosuspension product. From this study, logP and enthalpy were concluded to have a direct correlation on the feasibility of formation of a stable nanosuspension. The most likely candidate for media milling was a drug substance with a high enthalpy and hydrophobicity which can be stabilized either electrostatically or sterically. The least likely candidate will be one that is hydrophilic and having a very low enthalpy value. Also the choice of an ideal stabilizer/surfactant was found to be influenced by the degree of hydrophobicity of the drug itself. Finally the morphology of the starting drug was found to significantly affect the milling time required to produce submicron particles.

摘要

自上而下的湿法介质研磨已被证明是一种有效制备难溶性药物/API 纳米混悬剂的方法。迄今为止,几乎没有或没有尝试从稳定机制的角度来理解纳米混悬剂配方的可行性,这是药物性质的函数。本研究的目的是了解药物物质和稳定剂性质对形成成功的纳米混悬剂产品的影响。从这项研究中,可以得出结论,logP 和焓与形成稳定纳米混悬剂的可行性之间存在直接关系。最有可能成为介质研磨候选药物的是具有高热和疏水性的药物物质,可以通过静电或空间位阻来稳定。最不可能的候选药物是亲水性且焓值非常低的药物物质。此外,理想稳定剂/表面活性剂的选择也受到药物本身疏水性程度的影响。最后,发现起始药物的形态显著影响生产亚微米颗粒所需的研磨时间。

相似文献

1
Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.确定通过湿磨介质技术制备的纳米混悬剂制剂的药物/稳定剂性质与关键质量属性(CQAs)之间的相关性。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):142-52. doi: 10.1016/j.ejps.2012.10.004. Epub 2012 Oct 22.
2
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
3
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.用于提高难溶性药物生物利用度的纳米混悬剂和抑制晶体生长的稳定剂筛选。
Int J Pharm. 2011 May 16;409(1-2):260-8. doi: 10.1016/j.ijpharm.2011.02.051. Epub 2011 Mar 1.
4
Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.湿法制粒研磨制备的萘普生纳米混悬液的工艺参数依赖性生长现象
Eur J Pharm Biopharm. 2015 May;92:171-9. doi: 10.1016/j.ejpb.2015.02.031. Epub 2015 Mar 9.
5
Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.通用湿磨技术制备口服纳米混悬剂——专注于发现和临床前动物研究——开发粒子设计方法。
Int J Pharm. 2011 Feb 28;405(1-2):218-27. doi: 10.1016/j.ijpharm.2010.12.013. Epub 2010 Dec 16.
6
Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.对用于制备物理稳定纳米混悬液的不同表面改性剂进行系统筛选。
J Pharm Sci. 2015 Mar;104(3):1128-40. doi: 10.1002/jps.24266. Epub 2015 Jan 28.
7
Formulation and drying of miconazole and itraconazole nanosuspensions.米康唑和伊曲康唑纳米混悬剂的制备和干燥。
Int J Pharm. 2013 Feb 25;443(1-2):209-20. doi: 10.1016/j.ijpharm.2012.11.044. Epub 2013 Jan 4.
8
Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.通过湿磨介质技术制备纳米混悬剂的配方和工艺参数优化:维生素 E TPGS 和纳米晶体粒径对口服吸收的影响。
Eur J Pharm Sci. 2012 Nov 20;47(4):718-28. doi: 10.1016/j.ejps.2012.08.011. Epub 2012 Aug 24.
9
Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.采用自上而下介质研磨法研究纳米混悬剂的制备参数,以提高难溶性格列吡嗪的溶解度。
Eur J Pharm Biopharm. 2011 Aug;78(3):441-6. doi: 10.1016/j.ejpb.2011.03.014. Epub 2011 Mar 23.
10
Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.通过湿搅拌介质研磨连续生产药物纳米颗粒悬浮液:重新审视雷宾德效应。
Drug Dev Ind Pharm. 2013 Feb;39(2):266-83. doi: 10.3109/03639045.2012.676048. Epub 2012 Apr 16.

引用本文的文献

1
Characterisation and Stabilisation Mechanisms of Azelaic Acid Nanosuspensions: Insights from a Dual Stabiliser System.壬二酸纳米混悬液的表征及稳定机制:来自双稳定剂系统的见解
Pharmaceutics. 2025 Mar 29;17(4):439. doi: 10.3390/pharmaceutics17040439.
2
Comprehensive Aerodynamic and Physicochemical Stability Evaluations of Nanocrystal-Based Dry Powder Inhalers: The Role of Mannitol and Leucine in Enhancing Performance.基于纳米晶体的干粉吸入器的综合空气动力学和物理化学稳定性评估:甘露醇和亮氨酸在提升性能方面的作用
Pharmaceutics. 2025 Mar 28;17(4):436. doi: 10.3390/pharmaceutics17040436.
3
A Systematic Investigation of Process Parameters for Small-Volume Aqueous Suspension Production by the Use of Focused Ultrasonication.
采用聚焦超声法生产小体积水混悬液的工艺参数系统研究。
AAPS PharmSciTech. 2024 Aug 13;25(6):185. doi: 10.1208/s12249-024-02907-6.
4
Utilizing Molecular Simulations to Examine Nanosuspension Stability.利用分子模拟研究纳米混悬液的稳定性。
Pharmaceutics. 2023 Dec 28;16(1):0. doi: 10.3390/pharmaceutics16010050.
5
Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System.载有他莫昔芬的丙烯酸树脂纳米颗粒:基于质量源于设计方法优化作为递送系统的纳米颗粒
Pharmaceutics. 2023 Sep 22;15(10):2373. doi: 10.3390/pharmaceutics15102373.
6
Different Size Formulations of Fluopyram: Preparation, Antifungal Activity, and Accumulation in the Fungal Pathogen .不同大小规格氟吡菌酰胺制剂的制备、抗真菌活性及其在真菌病原体中的积累
Molecules. 2023 Aug 17;28(16):6099. doi: 10.3390/molecules28166099.
7
Nanocrystal Preparation of Poorly Water-Soluble Drugs with Low Metal Contamination Using Optimized Bead-Milling Technology.采用优化的珠磨技术制备低金属污染的难溶性药物纳米晶体
Pharmaceutics. 2022 Nov 28;14(12):2633. doi: 10.3390/pharmaceutics14122633.
8
Formulation and Process Optimization of Nanosuspension by HPMC and In Vitro Evaluation of ACE Inhibitory Potential.羟丙基甲基纤维素对纳米混悬剂的处方及工艺优化与ACE抑制潜力的体外评价
J Funct Biomater. 2022 Nov 30;13(4):268. doi: 10.3390/jfb13040268.
9
Impact of Excipients and Seeding on the Solid-State Form Transformation of Indomethacin during Liquid Antisolvent Precipitation.辅料和晶种对吲哚美辛在液体反溶剂沉淀过程中固态形式转变的影响
Cryst Growth Des. 2022 Oct 5;22(10):6056-6069. doi: 10.1021/acs.cgd.2c00678. Epub 2022 Sep 9.
10
Betamethasone Dipropionate Nanocrystals: Investigation, Feasibility and In Vitro Evaluation.倍他米松二丙酸纳米晶:研究、可行性和体外评价。
AAPS PharmSciTech. 2022 Jul 14;23(6):197. doi: 10.1208/s12249-022-02346-1.